[go: up one dir, main page]

AU2003210659A1 - Combination therapy for treatment of hiv infection - Google Patents

Combination therapy for treatment of hiv infection

Info

Publication number
AU2003210659A1
AU2003210659A1 AU2003210659A AU2003210659A AU2003210659A1 AU 2003210659 A1 AU2003210659 A1 AU 2003210659A1 AU 2003210659 A AU2003210659 A AU 2003210659A AU 2003210659 A AU2003210659 A AU 2003210659A AU 2003210659 A1 AU2003210659 A1 AU 2003210659A1
Authority
AU
Australia
Prior art keywords
treatment
combination therapy
hiv infection
hiv
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210659A
Other languages
English (en)
Inventor
Roland Buelow
Satya Dandekar
Suhasini Iyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangstat Medical Corp
Original Assignee
Sangstat Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangstat Medical Corp filed Critical Sangstat Medical Corp
Publication of AU2003210659A1 publication Critical patent/AU2003210659A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003210659A 2002-01-24 2003-01-24 Combination therapy for treatment of hiv infection Abandoned AU2003210659A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35192502P 2002-01-24 2002-01-24
US60/351,925 2002-01-24
PCT/US2003/002275 WO2003061602A2 (fr) 2002-01-24 2003-01-24 Therapie combinee pour le traitement d'infection vih

Publications (1)

Publication Number Publication Date
AU2003210659A1 true AU2003210659A1 (en) 2003-09-02

Family

ID=27613528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210659A Abandoned AU2003210659A1 (en) 2002-01-24 2003-01-24 Combination therapy for treatment of hiv infection

Country Status (5)

Country Link
US (1) US7094413B2 (fr)
EP (1) EP1525216A4 (fr)
AU (1) AU2003210659A1 (fr)
CA (1) CA2474056A1 (fr)
WO (1) WO2003061602A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224917A1 (en) 2003-01-14 2004-11-11 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
EP1663315B1 (fr) 2003-09-17 2011-01-05 Rodos BioTarget GmbH Preparations lipide-medicament pour l'administration ciblee de medicaments aux cellules immunitaires myeloides et lymphoides
US7498309B2 (en) 2003-11-29 2009-03-03 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents
WO2006072579A1 (fr) * 2005-01-05 2006-07-13 Foundation For Fatal Rare Disease Peptides antiviraux pharmaceutiquement actifs
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
SI1981506T1 (sl) * 2006-01-20 2013-08-30 Janssen R&D Ireland Dolgoročno zdravljenje infekcije HIV s TCM278
MX2010008148A (es) 2008-01-25 2010-10-20 Chimerix Inc Métodos de tratamiento de infecciones virales.
US20110135655A1 (en) * 2009-01-13 2011-06-09 PHILADELPHIA HEALTH AND EDUCATION CORPORATION d/b/a Drexel University College of Medicine; Role of PI3K p110 delta Signaling in Retroviral Infection and Replication
WO2011100698A2 (fr) 2010-02-12 2011-08-18 Chimerix, Inc. Méthodes de traitement d'une infection virale
US8642744B2 (en) * 2010-10-28 2014-02-04 Agilent Technologies, Inc. Crosslinking reagent for analysis of protein-protein interaction
WO2014088629A1 (fr) * 2012-12-07 2014-06-12 Salix Pharmaceuticals, Ltd Procédés et compositions pour le traitement de la diarrhée associée au vih

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
AU619458B2 (en) 1987-01-30 1992-01-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte inhibition by hla peptides
US5888512A (en) 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5385888A (en) * 1987-03-20 1995-01-31 The Regents Of The University Of California Class I MHC modulation or surface receptor activity
JP3015058B2 (ja) 1989-03-03 2000-02-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 表面レセプター活性のクラスｉｍｈｃ調節
DK0661985T3 (da) 1991-11-08 2000-01-31 Univ Leland Stanford Junior Peptider, der er i stand til at binde til CTL-prækursere
US5440015A (en) 1992-07-21 1995-08-08 Glycomed Incorporated Selectin peptide medicaments for treating disease
AU1093995A (en) 1993-11-10 1995-05-29 Board Of Trustees Of The Leland Stanford Junior University Surface membrane proteins and their effect on immune response
US6057294A (en) 1995-01-16 2000-05-02 Northern Sydney Area Health Service Of Pacific Highway Peptide
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
NZ311319A (en) * 1995-06-07 2000-01-28 Trimeris Inc The treatment of HIV and other viral infections using the peptide DP-178 or DP-107 in combination therapy
WO1997024140A1 (fr) 1996-01-02 1997-07-10 The Board Of Trustees Of Leland Stanford Junior University Interaction de proteines hla avec des membres de la famille hsp70 de proteines
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
AU3209897A (en) 1996-05-24 1997-12-09 Board Of Trustees Of The Leland Stanford Junior University Immunomodulating dimers
TR199902786T2 (xx) 1997-04-11 2000-06-21 Sangstat Medical Corporation Ba����kl�k sistemi faaliyetinin d�zene sokulmas� ve iltihaplanman�n durdurulmas� i�in lipofilik peptidlerin h�cre yap�s�n�n d�zene konulmas�.
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
EP1272510B1 (fr) * 2000-02-07 2007-09-26 Wisconsin Alumni Research Foundation Peptides antiviraux pharmacologiquement actifs et leurs methodes d'utilisation

Also Published As

Publication number Publication date
EP1525216A4 (fr) 2009-07-08
CA2474056A1 (fr) 2003-07-31
WO2003061602A3 (fr) 2005-02-03
US20040127422A1 (en) 2004-07-01
EP1525216A2 (fr) 2005-04-27
US7094413B2 (en) 2006-08-22
WO2003061602A2 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
AU2002368274A1 (en) Methods of treating infection by drug resistant bacteria
AU2003298043A1 (en) Surface treatment of medical device
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2002257936A1 (en) Methods of well treatment
AU2002342613A1 (en) Treatment for wounds
AU1167602A (en) Methods of therapy for hiv infection
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2002315814A1 (en) Medicinal composition for treatment of interstitial cystitis
AU2003903387A0 (en) Combination therapy for treatment of neoplasia
AU2003210659A1 (en) Combination therapy for treatment of hiv infection
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
AU2002319286A1 (en) Skin treatment
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2003268923A1 (en) Treatment of aml
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2003301012A1 (en) Use of beta-defensins for treating hiv infections
AU2003263332A1 (en) Wound dressings for the treatment of wound infection
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002360523A1 (en) Compounds to treat hiv infection and aids
AU2003243215A1 (en) Treatment for human papillomavirus
AU2003297570A1 (en) Treatment of skin diseases
AU2003304316A1 (en) Compounds and methods for the treatment and prevention of bacterial infection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase